References

Bates A, Laven R, Bork O, Hay M, McDowell J, Saldias B. Selective and deferred treatment of clinical mastitis in seven New Zealand dairy herds. Prev Vet Med. 2020; 176 https://doi.org/10.1016/j.prevetmed.2020.104915

British Veterinary Association. BVA position on the responsible use of antimicrobials in food producing animals. 2019. https://www.bva.co.uk/media/1161/bva-policy-position-on-the-responsible-use-of-antimicrobials-in-food-producing-animals-1.pdf

Down PM, Bradley AJ, Breen JE, Green MJ. Factors affecting the cost-effectiveness of on-farm culture prior to the treatment of clinical mastitis in dairy cows. Prev Vet Med. 2017; 145:91-99 https://doi.org/10.1016/j.prevetmed.2017.07.006

Ferreira JC, Gomes MS, Bonsaglia ECR Comparative analysis of four commercial on-farm culture methods to identify bacteria associated with clinical mastitis in dairy cattle. PLoS One. 2018; 13:(3) https://doi.org/10.1371/journal.pone.0194211

Fuenzalida MJ, Ruegg PL. Negatively controlled, randomized clinical trial to evaluate intramammary treatment of nonsevere, gram-negative clinical mastitis. J Dairy Sci. 2019; 102:(6)5438-5457 https://doi.org/10.3168/jds.2018-16156

Hillerton JE, Kliem KE. Effective treatment of Streptococcus uberis clinical mastitis to minimize the use of antibiotics. J Dairy Sci. 2002; 85:(4)1009-1014 https://doi.org/10.3168/jds.S0022-0302(02)74161-1

Lago A, Godden SM, Bey R, Ruegg PL, Leslie K. The selective treatment of clinical mastitis based on on-farm culture results: I. Effects on antibiotic use, milk with-holding time, and short-term clinical and bacteriological outcomes. J Dairy Sci. 2011a; 94:(9)4441-4456 https://doi.org/10.3168/jds.2010-4046

Lago A, Godden SM, Bey R, Ruegg PL, Leslie K. The selective treatment of clinical mastitis based on on-farm culture results: II. Effects on lactation performance, including clinical mastitis recurrence, somatic cell count, milk production, and cow survival. J Dairy Sci. 2011b; 94:(9)4457-4467 https://doi.org/10.3168/jds.2010-4047

McDougall S, Hussein H, Petrovski K. Antimicrobial resistance in Staphylococcus aureus, Streptococcus uberis and Streptococcus dysgalactiae from dairy cows with mastitis. N Z Vet J. 2014; 62:(2)68-76 https://doi.org/10.1080/00480169.2013.843135

Neave FK, Dodd FH, Kingwill RG, Westgarth DR. Control of mastitis in the dairy herd by hygiene and management. J Dairy Sci. 1969; 52:(5)696-707 https://doi.org/10.3168/jds.S0022-0302(69)86632-4

O'Neill J. Tackling drug-resistant infections globally: final report and recommendations.: HM Government; 2016

Pinzón-Sánchez C, Cabrera VE, Ruegg PL. Decision tree analysis of treatment strategies for mild and moderate cases of clinical mastitis occurring in early lactation. J Dairy Sci. 2011; 94:(4)1873-1892 https://doi.org/10.3168/jds.2010-3930

Pyörälä S. Treatment of mastitis during lactation. Ir Vet J. 2009; 62:(S4)S40-S44 https://doi.org/10.1186/2046-0481-62-S4-S40

Ruegg PL. Making Antibiotic Treatment Decisions for Clinical Mastitis. Vet Clin North Am Food Anim Pract. 2018; 34:(3)413-425 https://doi.org/10.1016/j.cvfa.2018.06.002

Schmenger A, Leimbach S, Wente N, Zhang Y, Biggs AM, Kroemker V. Implementation of a targeted mastitis therapy concept using an on-farm rapid test: antimicrobial consumption, cure rates and compliance. Vet Rec. 2020; 187:(10) https://doi.org/10.1136/vr.105674

Suojala L, Simojoki H, Mustonen K, Kaartinen L, Pyörälä S. Efficacy of enrofloxacin in the treatment of naturally occurring acute clinical Escherichia coli mastitis. J Dairy Sci. 2010; 93:(5)1960-1969 https://doi.org/10.3168/jds.2009-2462

Treating clinical mastitis in dairy herds: a role for on farm culture?

02 September 2021
10 mins read
Volume 26 · Issue 5
Figure 2. Collection of an aseptic sample for any on farm culture work and periodic submission to an independent laboratory is an essential part of mastitis treatment decision making.
Figure 2. Collection of an aseptic sample for any on farm culture work and periodic submission to an independent laboratory is an essential part of mastitis treatment decision making.

Abstract

The focus on the rational use of antibiotics in dairy herds has meant that mastitis control has received renewed interest, particularly around prevention of new infections and alternative treatment strategies. The former has seen the development of a new industry initiative (QuarterPRO) to help advisors and farmers reduce the rate of new infections and index cases. The latter has seen widespread uptake of the selective use of intramammary antibiotic for infected cows at drying-off, a reminder to the veterinary profession as well as clients about the general lack of evidence for the use of parenteral antibiotic in combination with intramammary antibiotic for mild and moderate clinical mastitis events, and finally the potential to select intramammary antibiotic treatment for clinical mastitis using on farm culture (OFC). It is important that veterinary surgeons are aware of the research around the development and use of OFC and the suitability of individual herds for this approach. Whereas antibiotics may not be required for mild clinical mastitis events caused by some pathogens, particularly Escherichia coli, it is important that clinical mastitis events (particularly first cases in a lactation cycle) caused by Gram-positive pathogens such as Streptococcus spp. and Staphylococcus aureus are treated with intramammary antibiotic to optimise chance of cure and reduce risk of transmission. With this in mind, we need to consider individual herd cell count data, herd pathogen profile and ensure careful monitoring of outcomes for clinical mastitis cases in herds that are selecting treatment based on OFC, particularly for index (first) cases in a cow's lactation.

The Five Point Plan for mastitis control developed in the UK during the 1960s was directed towards the control of those pathogens predominantly spread between cows during milking (so-called ‘contagious’ mastitis) and pathogens such as Staphylococcus aureus and Streptococcus agalactiae, but also relevant for other mastitis-causing pathogens, particularly other Gram-positive pathogens. Two of these five control measures were the importance of antibiotic dry cow therapy for all cows at drying-off and the prompt detection and treatment of all clinical cases of mastitis in lactation using an antibiotic (Neave et al, 1969). Therefore, the treatment of existing infections in cows at drying-off using an antibiotic and the treatment of clinical mastitis during lactation (visual changes to the milk and/or swelling of the affected quarter) using an antibiotic remain an important part of mastitis management in conventionally managed dairy herds in the UK as well as in other countries. In response to the publication of final recommendations from a UK government-commissioned report in 2016 (O'Neill, 2016), sector-specific targets for reducing or even replacing the use of antibiotics in UK food-producing animals were published (RUMA, 2017). For the dairy sector, these included four recommendations that related directly to mastitis control, including the use of lactating cow intramammary antibiotics.

Register now to continue reading

Thank you for visiting UK-VET Companion Animal and reading some of our peer-reviewed content for veterinary professionals. To continue reading this article, please register today.